Goldman Sachs Group Inc Vor Biopharma Inc. Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
A detailed history of Goldman Sachs Group Inc transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 28,227 shares of VOR stock, worth $33,590. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,227
Previous 375,342
92.48%
Holding current value
$33,590
Previous $375,000
94.93%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding VOR
# of Institutions
57Shares Held
41.2MCall Options Held
9.3KPut Options Held
100-
Ra Capital Management, L.P. Boston, MA22.7MShares$27.1 Million0.22% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA6.36MShares$7.57 Million1.77% of portfolio
-
Hudson Bay Capital Management LP Greenwich, CT2.47MShares$2.93 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$2.33 Million0.0% of portfolio
-
Cowen And Company, LLC1.22MShares$1.45 Million0.02% of portfolio
About Vor Biopharma Inc.
- Ticker VOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,056,300
- Market Cap $45.3M
- Description
- Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...